Gene therapy development
The company develops gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Genespire is a biotechnology company focused on developing gene therapies for patients affected by genetic diseases.
Its stated focus particularly includes primary immunodeficiencies and inherited metabolic diseases. Genespire is based in Milan, Italy, and was founded in March 2020.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company develops gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 15, 2026, September 18, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.